{
 "context": "The following article called 'Endo Health Rises On Report It May Put Itself Up for Sale' was published on 2013-01-30. The body of the article is as follows:\n    \nEndo Health Solutions Inc., (ENDP)  the\nmaker of the painkiller Lidoderm, rose the most in seven years\nafter a report said the drugmaker may sell itself.  The shares of the  Chadds Ford , Pennsylvania-based company\nclimbed 13 percent to $32.40 at 2:46 p.m. New York time after\nreaching $33.32 in the highest intraday increase since June\n2005. Reuters cited unidentified sources in its article.  Blaine Davis, a spokesman for Endo, didn\u2019t immediately\nreturn a voice-mail message seeking comment about the possible\nsale.  To contact the reporter on this story:\nRyan Flinn in San Francisco at \n rflinn@bloomberg.net   To contact the editor responsible for this story:\nReg Gale at \n rgale5@bloomberg.net\n\n    The day before the article was published, the stock price of Endo Health Solutions Inc. was 28.579999923706055 and the day after the article was published, the stock price of Endo Health Solutions Inc. was ",
 "expected": "31.65999984741211",
 "date": "2013-01-30",
 "ticker": "ENDP",
 "company": "Endo Health Solutions Inc.",
 "url": "http://www.bloomberg.com/news/2013-01-30/endo-health-rises-on-report-it-may-put-itself-up-for-sale.html"
}